CR7351A - Composicion de la preparacion que contiene el compuesto fisiologico activo de acido inestable el proceso para producirla - Google Patents
Composicion de la preparacion que contiene el compuesto fisiologico activo de acido inestable el proceso para producirlaInfo
- Publication number
- CR7351A CR7351A CR7351A CR7351A CR7351A CR 7351 A CR7351 A CR 7351A CR 7351 A CR7351 A CR 7351A CR 7351 A CR7351 A CR 7351A CR 7351 A CR7351 A CR 7351A
- Authority
- CR
- Costa Rica
- Prior art keywords
- composition
- preparation
- active compound
- physiologically active
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se intenta divulgar la composicion de la preparacion que permita la produccion conveniente de composicion de preparacion de liberacion sostenida que contenga un compuesto fisiologicamente activo inestable en acido y que tenga las propiedades deseadas de liberacion sostenida. A saber, la composicion de la preparacion que comprende una masa central que contiene un compuesto fisiologicamente activo inestable en acido y una capa con la que la masa central esta cubierta y que contiene una mezcla de un polimero insoluble en agua y un polimero enterico. La composicion de la preparacion de acuerdo a la presente invencion hace posible mantener una concentracion efectiva de sangre del compuesto fisiologicamente activo durante largo tiempo, mejorando asi su efecto terapeutico. Ademas, la composicion de acuerdo a la presente invencion permanece estable durante el almacenamiento prolongado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001356018 | 2001-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR7351A true CR7351A (es) | 2005-05-12 |
Family
ID=19167613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR7351A CR7351A (es) | 2001-11-21 | 2004-05-20 | Composicion de la preparacion que contiene el compuesto fisiologico activo de acido inestable el proceso para producirla |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1454634A4 (es) |
JP (1) | JP4540092B2 (es) |
KR (1) | KR20050044545A (es) |
CN (2) | CN101982199A (es) |
AP (1) | AP1919A (es) |
AU (1) | AU2002366029B2 (es) |
BR (1) | BR0214372A (es) |
CA (1) | CA2466726C (es) |
CO (1) | CO5580800A2 (es) |
CR (1) | CR7351A (es) |
EC (1) | ECSP045110A (es) |
HU (1) | HUP0402323A3 (es) |
IL (2) | IL161983A0 (es) |
IS (1) | IS7266A (es) |
MA (1) | MA26346A1 (es) |
MX (1) | MXPA04004775A (es) |
NO (1) | NO20042563L (es) |
NZ (1) | NZ532907A (es) |
RO (1) | RO122395B1 (es) |
RU (1) | RU2311906C2 (es) |
SI (1) | SI21447A (es) |
TW (1) | TWI302461B (es) |
UA (1) | UA76256C2 (es) |
WO (1) | WO2003043661A1 (es) |
ZA (1) | ZA200403551B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
JPWO2005092336A1 (ja) * | 2004-03-26 | 2008-02-07 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 溶出制御製剤とその製造方法 |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
CA2584957C (en) | 2004-10-21 | 2015-08-25 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US8481565B2 (en) | 2004-12-27 | 2013-07-09 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
US20080213381A1 (en) * | 2005-03-14 | 2008-09-04 | Pharmaceutical Industries Limited | Oral Drug Delivery System |
WO2006111853A2 (en) * | 2005-04-18 | 2006-10-26 | Aurobindo Pharma Limited | Stable solid dosage forms of acid labile drug |
US9161918B2 (en) * | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
WO2008062320A2 (en) | 2006-10-06 | 2008-05-29 | Eisai R&D Management Co., Ltd | Extended release formulations of a proton pump inhibitor |
CN101878041A (zh) * | 2007-11-27 | 2010-11-03 | 大原药品工业株式会社 | 颗粒制剂的制造方法 |
CN101822671A (zh) * | 2009-03-06 | 2010-09-08 | 信谊药厂 | 雷贝拉唑组合物及其制备方法 |
SG10201407965XA (en) | 2009-12-02 | 2015-02-27 | Aptalis Pharma Ltd | Fexofenadine microcapsules and compositions containing them |
NZ605562A (en) * | 2010-07-09 | 2013-11-29 | Teijin Pharma Ltd | Deuterated benzylbenzene derivatives and methods of use |
JP2018184360A (ja) * | 2017-04-25 | 2018-11-22 | ニプロ株式会社 | 経口投与用の腸溶性徐放性製剤 |
KR102227486B1 (ko) * | 2017-06-30 | 2021-03-12 | 롯데정밀화학 주식회사 | 프로톤 펌프 저해제를 포함하는 경구용 고형제제 조성물, 이를 포함하는 경구용 고형제제 및 그 제조방법 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
JPS5944311A (ja) * | 1982-09-07 | 1984-03-12 | Santen Pharmaceut Co Ltd | 徐放性顆粒およびその製造法 |
DE69020758T2 (de) * | 1989-03-10 | 1995-12-07 | Yamanouchi Pharma Co Ltd | Die Wirkstoffabgabe steuerndes Überzugsmaterial für lang wirksame Formulierungen. |
EP0447168A3 (en) * | 1990-03-16 | 1993-01-07 | Yamanouchi Pharmaceutical Co. Ltd. | Long acting granular pharmaceutical composition |
JPH0826977A (ja) * | 1994-07-19 | 1996-01-30 | Tanabe Seiyaku Co Ltd | 溶出制御型経口製剤 |
JPH09323926A (ja) * | 1996-03-15 | 1997-12-16 | Nikken Chem Co Ltd | バルプロ酸ナトリウムの徐放性錠剤 |
ES2137862B1 (es) * | 1997-07-31 | 2000-09-16 | Intexim S A | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. |
CA2298823C (en) * | 1998-04-20 | 2011-06-07 | Eisai Co., Ltd. | Stabilized composition comprising a benzimidazole type compound |
EP1121103B1 (en) * | 1998-05-18 | 2006-12-20 | Takeda Pharmaceutical Company Limited | Orally disintegrable tablets comprising a benzimidazole |
JP2001055322A (ja) * | 1999-08-18 | 2001-02-27 | Tanabe Seiyaku Co Ltd | パルス放出型製剤 |
CA2387746C (en) * | 1999-10-20 | 2010-06-29 | Koji Ukai | Methods for stabilizing benzimidazole-based compounds |
US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
-
2002
- 2002-11-20 RU RU2004118495/15A patent/RU2311906C2/ru not_active IP Right Cessation
- 2002-11-20 HU HU0402323A patent/HUP0402323A3/hu unknown
- 2002-11-20 EP EP02803548A patent/EP1454634A4/en not_active Withdrawn
- 2002-11-20 SI SI200220036A patent/SI21447A/sl not_active IP Right Cessation
- 2002-11-20 CN CN2010105157913A patent/CN101982199A/zh active Pending
- 2002-11-20 AU AU2002366029A patent/AU2002366029B2/en not_active Ceased
- 2002-11-20 AP APAP/P/2004/003045A patent/AP1919A/en active
- 2002-11-20 RO ROA200400455A patent/RO122395B1/ro unknown
- 2002-11-20 CN CNA02823233XA patent/CN1589156A/zh active Pending
- 2002-11-20 CA CA2466726A patent/CA2466726C/en not_active Expired - Fee Related
- 2002-11-20 WO PCT/JP2002/012132 patent/WO2003043661A1/ja active Application Filing
- 2002-11-20 JP JP2003545339A patent/JP4540092B2/ja not_active Expired - Fee Related
- 2002-11-20 UA UA20040604883A patent/UA76256C2/uk unknown
- 2002-11-20 NZ NZ532907A patent/NZ532907A/en not_active IP Right Cessation
- 2002-11-20 MX MXPA04004775A patent/MXPA04004775A/es active IP Right Grant
- 2002-11-20 KR KR1020047007672A patent/KR20050044545A/ko active Search and Examination
- 2002-11-20 BR BR0214372-0A patent/BR0214372A/pt not_active IP Right Cessation
- 2002-11-20 IL IL16198302A patent/IL161983A0/xx unknown
- 2002-11-21 TW TW091133989A patent/TWI302461B/zh not_active IP Right Cessation
-
2004
- 2004-05-10 ZA ZA200403551A patent/ZA200403551B/en unknown
- 2004-05-13 IL IL161983A patent/IL161983A/en active IP Right Review Request
- 2004-05-14 IS IS7266A patent/IS7266A/is unknown
- 2004-05-17 EC EC2004005110A patent/ECSP045110A/es unknown
- 2004-05-18 CO CO04045751A patent/CO5580800A2/es not_active Application Discontinuation
- 2004-05-18 MA MA27683A patent/MA26346A1/fr unknown
- 2004-05-20 CR CR7351A patent/CR7351A/es unknown
- 2004-06-18 NO NO20042563A patent/NO20042563L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPWO2003043661A1 (ja) | 2005-03-10 |
UA76256C2 (en) | 2006-07-17 |
IL161983A0 (en) | 2005-11-20 |
HUP0402323A3 (en) | 2008-04-28 |
ECSP045110A (es) | 2004-08-27 |
CO5580800A2 (es) | 2005-11-30 |
BR0214372A (pt) | 2004-10-26 |
MA26346A1 (fr) | 2004-10-01 |
CA2466726C (en) | 2011-02-22 |
AP1919A (en) | 2008-11-13 |
ZA200403551B (en) | 2005-07-07 |
EP1454634A1 (en) | 2004-09-08 |
RU2004118495A (ru) | 2005-03-20 |
KR20050044545A (ko) | 2005-05-12 |
IS7266A (is) | 2004-05-14 |
RU2311906C2 (ru) | 2007-12-10 |
AU2002366029A1 (en) | 2003-06-10 |
SI21447A (sl) | 2004-10-31 |
AP2004003045A0 (en) | 2004-06-30 |
CA2466726A1 (en) | 2003-05-30 |
EP1454634A4 (en) | 2007-05-30 |
NZ532907A (en) | 2007-05-31 |
NO20042563L (no) | 2004-06-18 |
TW200300353A (en) | 2003-06-01 |
CN101982199A (zh) | 2011-03-02 |
JP4540092B2 (ja) | 2010-09-08 |
WO2003043661A1 (fr) | 2003-05-30 |
MXPA04004775A (es) | 2005-02-17 |
RO122395B1 (ro) | 2009-05-29 |
AU2002366029B2 (en) | 2008-01-31 |
TWI302461B (en) | 2008-11-01 |
HUP0402323A2 (hu) | 2005-02-28 |
IL161983A (en) | 2009-11-18 |
CN1589156A (zh) | 2005-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR7351A (es) | Composicion de la preparacion que contiene el compuesto fisiologico activo de acido inestable el proceso para producirla | |
US20200179558A1 (en) | Dressing System | |
ES2262173T3 (es) | Potenciadores de la penetracion dermica y sistemas de aporte de farmacos que los utilizan. | |
ES2432164T3 (es) | Composición estabilizada que comprende al menos un compuesto adrenérgico | |
PE20030399A1 (es) | Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa | |
AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
GT199900072A (es) | Jarabe antihistaminico estabilizado. | |
ES2142644T3 (es) | Procedimiento para la obtencion de una disolucion de infusion y dialisis que contiene bicarbonato. | |
AR015524A1 (es) | FORMULACIoN ESTABLE DE SOLUCIoN DE OXIPLATINO, SU USO PARA LA MANUFACTURA DE UN MEDICAMENTO, PROCESO PARA SU PREPARACIoN, PRODUCTO FARMACÉUTICO QUE LA CONTIENE Y UN MÉTODO PARA ESTABILIZAR UNA SOLUCIoN DE OXALIPLATINO. | |
SV2004001418A (es) | Formulaciones farmaceuticas de 5,7,14-triazaciclo 10.3.1.0.2,11.04,9) -hexadeca-2(11),3,5,7,9-pentaeno" ref.pc 23248 | |
CY1106055T1 (el) | Τυποποιηση των υποκατεστημενων βενζιμιδαζολων | |
BR0013357A (pt) | Vacina | |
PT1383752E (pt) | 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos | |
AR037048A1 (es) | Agentes antidisritmicos administrados vaginalmente para tratar el dolor pelvico | |
CN102369004A (zh) | 银屑病的治疗 | |
ATE339224T1 (de) | Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung | |
AR006892A1 (es) | Uso de formas del acido hialuronico (ha) para el tratamiento del cancer | |
NO20023875L (no) | Stabilt nasalt, oralt eller sublingualt anvendbart preparat | |
CA2425218A1 (en) | Pharmaceutical solutions of modafinil compounds | |
BR0210224A (pt) | Formas de dosagem projetada para ser engolida diretamente e apresentada como uma formulação em comprimido ou cápsula deglutìvel, e, processo para preparação de uma forma de dosagem | |
RU2010122064A (ru) | Галеновая форма для чресслизистого введения парацетамола | |
CO5160272A1 (es) | Combinacion de cerivastatina y fibratos | |
ES2875624T3 (es) | Formulación gelificante a base de gluconato de calcio | |
ES2401402T3 (es) | Comprimidos efervescentes y gránulos efervescentes que contienen tartrato de carnitina | |
CN101642467B (zh) | 长效消毒膏 |